Daniel Krcelic, MD
Vascular Surgery · Mesa, AZNPI 1114289774
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,696 of the $9,999 with a category attached, or 87.0%. It is spread thinly across 26 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations.
Across 164 payments — averaging $60.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$2K
- Medtronic$2K
- Silk Road Medical, Inc.$1K
- W. L. Gore & Associates, Inc.$1K
- Philips North America LLC$707
- Inari Medical, Inc.$555
- plus $3K from 20 others
What the payments were for
- Consulting fees$1672%
- Travel & lodging$1,13611%
- Food & beverage$8,69687%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endologix LLC | 11 | $2,085 |
| Medtronic(2 entities) | 32 | $1,624 |
| Silk Road Medical, Inc. | 15 | $1,239 |
| W. L. Gore & Associates, Inc. | 20 | $1,163 |
| Philips North America LLC | 19 | $707 |
| Inari Medical, Inc. | 6 | $555 |
| Cook Medical LLC | 10 | $358 |
| Cardiovascular Systems Inc. | 4 | $318 |
| Bard Peripheral Vascular, Inc. | 5 | $276 |
| Terumo Medical Corporation | 1 | $268 |
| Abbott | 2 | $209 |
| Johnson & Johnson(2 entities) | 7 | $199 |
| Balt USA, LLC | 3 | $194 |
| Dilon Technologies, Inc. | 2 | $150 |
| Asahi Intecc USA, Inc. | 2 | $143 |
| Boston Scientific | 6 | $121 |
| Biotronik Inc. | 1 | $85 |
| Baxter Healthcare | 3 | $65 |
| E.r. Squibb & Sons, L.L.C. | 4 | $58 |
| Lemaitre Vascular, Inc. | 4 | $56 |
| Reflow Medical Inc | 2 | $34 |
| Bolton Medical Inc | 1 | $29 |
| Mimedx Group, Inc. | 1 | $17 |
| Artivion, Inc. | 1 | $16 |
| Smith+Nephew | 1 | $15 |
| Advanced Oxygen Therapy Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Torus Stent Graft System$1,052
- ENDOCROSS Device$1,052
- ENROUTE Transcarotid Neuroprotection System$949
- ENROUTE Transcarotid Stent System$949
- ENHANCE Transcarotid Peripheral Access Kit$949
- ENROUTE 0.014 Guidewire$949
- Alto Abdominal Stent Graft System$536
- AFX2 Bifurcated Endograft System$494
- FLOWTRIEVER CATHETER, S$428
- CT THROMBECTOMY SYSTEM KIT$428
- ENDURANT IIS$410
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$269
- GLIDESHEATH SLENDER$268
- Endurant$235
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$218
- Diamondback Peripheral$214
- Diamondback Coronary$214
- HawkOne$199
- GORE VIABAHN VBX Balloon Expandable Endo$143
- GORE TAG Thoracic Branch Endoprosthesis$143
How this compares
$9,999 in reported general payments places this provider in the 60th percentile of 105 vascular surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 33 | $32,042 |
| EliquisApixaban | 16 | $10,067 |
| ClopidogrelClopidogrel Bisulfate | 235 | $2,306 |
| Cilostazol | 80 | $1,481 |
| Enoxaparin Sodium | 11 | $645 |
| Atorvastatin Calcium | 43 | $350 |
| Pentoxifylline | 16 | $299 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $53 |
| Tramadol Hcl | 12 | $25 |
| Diazepam | 23 | $18 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $199 | $32,04233 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 105 vascular surgery providers in Arizona.
Other vascular surgery in Mesa
- Hammad AmerMesa$169K
- Xiaoyi LiMesa$16K
- David PaoliniMesa$9K
- Stacey HancockMesa$7K
- Henry TarlianMesa$6K
- Paul RiesenmanMesa$5K
- Venkatesh RamaiahScottsdale$452K
- Jeromy BrinkPhoenix$392K
- Luis LeonPhoenix$185K
- Baljeet UppalSun City$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.